Amedisys Home Health Of Baltimore | |
19 Newport Drive, Ste 201, Forest Hill, Maryland 21050 | |
(410) 420-6412 | |
Name | Amedisys Home Health Of Baltimore |
---|---|
Location | 19 Newport Drive, Ste 201, Forest Hill, Maryland |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 217045 |
Ownership Type | Proprietary |
Service Area Zip Codes | 21001, 21005, 21009, 21014, 21015, 21017, 21028, 21034, 21040, 21047, 21050, 21078, 21084, 21087, 21111, 21120, 21132, 21154, 21160, 21161 |
NPI Number | 1245553239 |
Organization Name | TENDER LOVING CARE HEALTH CARE SERVICES SOUTHEAST, L.L.C. |
Doing Business As | AMEDISYS HOME HEALTH OF BEL AIR |
Address | 19 Newport Dr, Suite 201, Forest Hill, MD 21050 |
Phone Number | 410-420-6412 |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
NPI Number | 1295789360 |
Organization Name | TENDER LOVING CARE HEALTH CARE SERVICES SOUTHEAST, LLC |
Doing Business As | AMEDISYS HOME HEALTH CARE |
Address | 134 Industry Ln Ste 3, Forest Hill, MD 21050 |
Phone Number | 410-420-6412 |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
Quality Rating: |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.7 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.4 | 99.6 |
How often the home health team checked patients for depression | 94.1 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 77.8 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 79.8 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 93.7 | 96.4 |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 84.2 | 79.6 |
How often patients got better at getting in and out of bed | 88.3 | 81.1 |
How often patients got better at bathing | 86.7 | 82.3 |
How often patients’ breathing improved | 89.5 | 82.8 |
How often patients’ wounds improved or healed after an operation | 96.9 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 81 | 75 |
How often home health patients had to be admitted to the hospital | 13.4 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 96.3 | 94 |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
The patient survey data of Amedisys Home Health Of Baltimore is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 94 | 88 |
Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 90 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 87 | 78 |
News Archive
The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
› Verified 5 days ago
Amedisys Home Health Of Baltimore Location: 19 Newport Drive, Ste 201, Forest Hill, Maryland 21050 Ratings: Phone: (410) 420-6412 |